# Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation

> **NCT00219583** · PHASE2,PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 460 (—)

## Conditions studied

- Ejaculation

## Interventions

- **DRUG:** UK-390,957

## Key facts

- **NCT ID:** NCT00219583
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 460 (—)
- **Last updated:** 2012-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00219583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00219583, "Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00219583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*